Romidepsin targets multiple survival signaling pathways in malignant T cells

por Valdez, B C, Brammer, J E, Li, Y, Murray, D, Liu, Y, Hosing, C, Nieto, Y, Champlin, R E, Andersson, B S
Publicado 2015

Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies

por Lekakis, L, Giralt, S, Couriel, D, Shpall, E J, Hosing, C, Khouri, I F, Anderlini, P, Korbling, M, Martin, T, Champlin, R E, de Lima, M
Publicado 2006